Multiple Organ Failure: Clinical Trials

11 trials for Multiple Organ Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown, 2 withdrawn, 1 terminated. 11 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Completed 6, Unknown 2, Withdrawn 2, Terminated 1
Phase 21Completed 1

Follow Multiple Organ Failure: new trials by email Literature Review of Multiple Organ Failure trials Research Report on Multiple Organ Failure

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dalargin for Prevention of Organ Disfunction in High-Risk Abdominal Surgery
Dalargin, 0.9 % NaCl - Postoperative Complications, Multiple Organ Failure
Phase 3CompletedBotkin Hospital2002025-05-132026-09-23
Efficacy of Coenzyme Q10 Supplementation on Multi-Organ Dysfunction in Severely Burned Patients
CoQ10, Placebo - Multiple Organ Failure
Phase 3WithdrawnAmerican Burn Association2018-07-012023-07-20
Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System
Clarithromycin, Water for injection - Sepsis, Pneumonia
Phase 3CompletedHellenic Institute for the Study of Sepsis1102017-12-152020-12-22
Vitamin D Status in Patients With Severe Sepsis
vitamin D3, Placebo - Sepsis, Severe Sepsis
Phase 3WithdrawnMassachusetts General Hospital2017-12-012021-05-05
Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients
Glutamin, Maltodextrin - Critical Illness, Enteral Nutrition
Phase 3CompletedShahid Beheshti University2002016-11-102018-10-16
Supplemental Parenteral Nutrition in Critically Ill Adults: A Pilot Randomised Controlled Trial
Supplemental PN, Standard Care - Multiple Organ Failure, Critical Illness
Phase 2 / Phase 3CompletedAustralian and New Zealand Intensive Care Research Centre1002014-02-012016-08-02
Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture
C1-esterase inhibitor, Saline 0.9% - Trauma, Inflammation
Phase 3TerminatedUMC Utrecht112012-04-012015-02-04
L-citrulline Supplementation During Sepsis
L-citrulline supplementation, L-alanine - Sepsis, Multiple Organ Failure
Phase 3UnknownMaastricht University Medical Center482011-01-012010-09-03
Cyclosporine A in Cardiac Arrest
Cyclosporine A, cardio-pulmonary resuscitation - Non Shockable Out of Hospital Cardiac Arrest
Phase 3CompletedHospices Civils de Lyon7962010-06-012025-08-28
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients
Defibrotide - Severe Hepatic Veno-Occlusive Disease
Phase 3CompletedJazz Pharmaceuticals1342006-07-012017-01-30
Effect of Rosiglitazone on ADMA in Critical Illness
Rosiglitazone - Critical Illness, Multiple Organ Failure
Phase 3UnknownAmsterdam UMC, location VUmc302006-04-012006-12-08

Narrower conditions

Critical Illness (4)  ·  Sepsis (4)  ·  Inflammation (2)  ·  Angioedemas, Hereditary (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Heart Arrest (1)  ·  Hepatic Veno-Occlusive Disease (1)  ·  Pneumonia (1)  ·  Post-Cardiac Arrest Syndrome (1)  ·  Postoperative Complications (1)  ·  Respiratory Distress Syndrome (1)  ·  Spinocerebellar ataxia 23 (1)  ·  Wounds and Injuries (1)

Broader conditions

Pathologic Processes (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Shock (11)  ·  Disease Attributes (4)  ·  Infections (4)  ·  Systemic Inflammatory Response Syndrome (4)  ·  Cardiovascular Diseases (3)  ·  Inflammation (3)  ·  Vascular Diseases (3)  ·  Angioedema (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Brain Diseases (1)  ·  Brain Injuries (1)  ·  Central Nervous System Diseases (1)

Interventions

Sodium Chloride (2)  ·  Alanine (1)  ·  Cardiopulmonary Resuscitation (1)  ·  Cholecalciferol (1)  ·  Clarithromycin (1)  ·  Complement C1 Inhibitor Protein (1)  ·  Cyclosporine (1)  ·  Dietary Supplements (1)  ·  Glutamine (1)  ·  Injections (1)  ·  Rosiglitazone (1)  ·  Saline Solution (1)  ·  Standard of Care (1)  ·  Water (1)  ·  coenzyme Q10 (1)

Sponsors

American Burn Association (1)  ·  Amsterdam UMC, location VUmc (1)  ·  Australian and New Zealand Intensive Care Research Centre (1)  ·  Botkin Hospital (1)  ·  Hellenic Institute for the Study of Sepsis (1)  ·  Hospices Civils de Lyon (1)  ·  Jazz Pharmaceuticals (1)  ·  Maastricht University Medical Center (1)  ·  Massachusetts General Hospital (1)  ·  Shahid Beheshti University (1)  ·  UMC Utrecht (1)

Countries

Netherlands (3)  ·  United States (3)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Greece (1)  ·  Iran (1)  ·  New Zealand (1)  ·  Russia (1)

Top investigators

Apostolos Armaganidis, MD, PhD (1)  ·  Herb Phelan, MD (1)  ·  Luke P Leenen, MD, PhD (1)  ·  Martijn Poeze, MD, PhD (1)  ·  Paul Richardson, M.D. (1)  ·  Sadeq A Quraishi, MD (1)  ·  Zahra Vahdat Shariatpanahi, MD, PhD (1)

Results publications

PMID 10933646, PMID 18444850, PMID 20610825, PMID 21988742, PMID 22564837, PMID 24292991, PMID 26703919, PMID 26825712, PMID 27044546, PMID 27433815, PMID 29361959, PMID 34116828, PMID 35717241

NIH funding

2009 (1)